The recently defined ligand for the Mpl receptor, thrombopoietin (TPO), has been found to be the principal regulatory cytokine of megakaryocytopoiesis. Furthermore, it has been hypothesized that direct interaction between stroma or stromaderived extracellular matrix (ECM) and human progenitor cells (HPC) may modulate megakaryocytopoiesis. For that purpose, we studied megakaryocytic development of HPC, obtained from patients with hematological malignancies in complete remission or solid tumors without bone marrow involvement, under the influence of megakaryocyte growth and development factor (MGDF, a pegylated, truncated molecule related to the endogenous Mpl ligand). The megakaryocytic development of HPC cultured in contact with a stromal layer (contact cultures) was compared with cultures in which HPC were grown separated from a stromal layer by a microporous membrane (noncontact cultures). A significantly lower number of megakaryocytes (CD41-and CD61-positive cells) was obtained from contact cultures compared to non-contact cultures. Furthermore, the expression of CD42b was higher in non-contact cultures, as compared to contact cultures, indicating an increase in megakaryocyte maturation in non-contact cultures. In contrast, no difference in clonogenic capacity was observed (CFU-GM, BFU-E, CFU-Mk). The possibility that direct contact between HPC and stroma induces the production of a soluble inhibitory cytokine as an explanation for the diminished megakaryocytic development in contact cultures, was excluded by performing transwell experiments in which HPC were cultured in direct contact and in a transwell simultaneously. The percentage of megakaryocytes raised from HPC present in the transwell did not decrease, irrespective of the presence of HPC simultaneous below the transwell in direct contact with stroma. It is concluded that both megakaryocytic development out of HPC and megakaryocytic differentiation is reduced in contact cultures, as compared to non-contact cultures. This is due to modulation by adhesive interactions with stroma, stromaderived ECM or cytokines bound to the membrane of stromal cells, rather than resulting from the production of diffusible cytokines by stromal cells.
Introduction
The regulation of human megakaryocytopoiesis is a complex process that involves both soluble mediators, such as cytokines, and direct cell adhesive interactions within the bone marrow environment. [1] [2] [3] The recently defined ligand for the Mpl receptor, thrombopoietin (TPO), has been found to be the principal regulatory cytokine of megakaryocytopoiesis and thrombopoiesis. [4] [5] [6] [7] [8] It appears that TPO is able not only to induce differentiation of megakaryocytic precursors, but also to expand early megakaryocytic progenitors. 9, 10 TPO also directly affects more primitive hematopoietic cells, not yet committed towards the megakaryocytic lineage. This turned out to be dependent on the co-presence of pluripotent cytokines, 11, 12 although a direct effect of thrombopoietin on CD34 + Thy-1 + Lin − -cells, which are representative for primitive, not yet lineage-committed, progenitor cells, without necessity of other cytokines has been reported. 13 Apart from cytokines, the development of megakaryocytes is modulated by cell adhesive interactions. Studies on the cellular interactions between megakaryocytes and stromal cells reveal that different subsets of bone marrow stromal cells play different roles in the proliferation and differentiation of megakaryocytes. Adhesion of megakaryocytes to human umbilical vein endothelial cells induces differentiation. 14 In contrast, adhesion to bone marrow fibroblasts results in proliferation instead of differentiation. 15 However, little is known about the influence of the interaction between human progenitor cells (HPC) and stromal elements on megakaryocytic development out of HPC. Direct contact between HPC and human bone marrow endothelial cells has been reported to augment megakaryocyte proliferation. 16 On the other hand a study on proliferation of early megakaryocytic progenitors, defined as BFU-Mk, indicated that interaction of HPC with extra-cellular-matrix (ECM) proteins and cytokines was not sufficient to initiate megakaryocytic proliferation. 17 In preliminary experiments, we showed that megakaryocytic development of HPC under the influence of megakaryocyte growth and development factor (MGDF, a pegylated, truncated molecule related to the endogenous Mpl ligand) was more pronounced when HPC were cultured without stroma than when HPC were cultured in direct contact with a stromal layer. 18 Thus, direct interaction of HPC with stroma or stroma-derived ECM may modulate megakaryocytopoiesis, which has also been suggested by Schattner. 19 However, the mechanisms through which modulation is exerted have not yet been elucidated.
In view of these considerations, we studied megakaryocytic development of human progenitor cells, cultured in contact with a stromal layer compared with cultures in which HPC were grown separated from a stromal layer by a microporous membrane. We found that direct contact between human progenitor cells and stroma negatively influences megakaryocytic development out of HPC in the presence of MGDF. Additional experiments to reveal the mechanism by which this effect is exerted are presented.
Materials and methods

Hematopoietic progenitor cell source and isolation
HPC were obtained from leukapheresis material from patients (after informed consent) with acute myeloid leukemia in first remission, with a relapse of non-Hodgkin lymphoma without marrow involvement or with solid tumors without marrow involvement. HPC from patients with acute myeloid leukemia were harvested after the second chemotherapy course (highdose cytarabine and amsacrine). HPC from patients with nonHodgkin lymphoma were harvested after the first course of their reinduction chemotherapy (Ifosfamide, methotrexate and etoposide). 20 Patients were mobilized with G-CSF 600 g/m 2 or 10 g/kg for 5 days. HPC of patients with solid tumors were in most cases harvested prior to the start of chemotherapy, using G-CSF 10 g/kg for 3-5 days. In some experiments the thawed cryopreserved light density fraction of bone marrow harvest from the same patient categories was used, as indicated in Table 6 . Red cells present in the leukapheresis material or in the thawed cryopreserved light density fraction of bone marrow, were lysed with ammonium chloride, for 8 min on ice. For isolation of CD34-positive cells the Mini-Macs CD34 isolation kit (Myltenyi, Bergisch Gladbach, Germany) was used, according to the instructions of the manufacturer. Briefly, cells were incubated with a hapten-conjugated CD34 mAb (Qbend 10), washed and incubated with magnetic microbeads conjugated to an anti-hapten antibody. Subsequently, cells were allowed to flow through a positive selection column in a magnetic field. The column was washed with phosphate buffered saline (PBS) with 5 mm EDTA and 0.1% bovine serum albumin (BSA, ICN Biomedicals, Aurora, OH, USA). CD34-positive cells were collected after taking the column off the magnet. After two consecutive passages through the columns, purity was always more than 90% as determined by flow cytometry using a CD34 mAb coupled to phycoerythrin (HPCA2, Becton Dickinson, Mountain View, CA, USA). Since CD34-positive cells, isolated from leukapheresis material, have been reported to stain false-positively with GPIIb/IIIa antibodies, caused by non-specific binding of platelets or platelet dust to CD34-positive cells, 21 cells were washed three times with PBS and 5 mm EDTA.
Murine stromal cell line
The murine fibroblastic cell line, M2-10B4, was kindly provided by CJ Eaves (Terry Fox Laboratory, Vancouver, Canada). This cell line was engineered to produce recombinant human IL-3 by transfection with a retrovirus encoding the cDNA of rhIL-3. Significant and sustained production of rhIL-3 has been demonstrated, as well as support of in vitro human hematopoiesis. [22] [23] [24] The cell line was maintained in RPMI 1640 medium, supplemented with 10% fetal bovine serum, at 37°C in a humidified atmosphere flushed with 5% CO 2 in air. After harvesting, the cells were irradiated by 15 Gy using a cobalt irradiator.
Bone marrow stroma
In order to obtain feeder layers, human bone marrow cultures were initiated with samples obtained from patients undergoing cardiac surgery, who gave informed consent. Mononuclear cells were isolated from the samples by Ficoll-Paque (Pharmacia, Uppsala, Sweden) density gradient centrifugation (␦ = 1.077 g/cm 3 ) and subsequently cultured in long-term bone marrow culture (LTBMC) medium (2 × 10 6 cells/ml): alfa medium supplemented with 12.5% horse serum, 12.5% fetal calf serum, 10 −4 m ␤-mercaptoethanol, 10 −6 m hydrocortisone sodium succinate, glutamine, penicillin and streptomycin.
After 2 weeks of culturing the adherent stromal cell layer was harvested using trypsin (all Gibco, Grand Island, NY, USA), irradiated with 15 Gy using a cobalt irradiator and replated in 24-wells plates (Costar, Cambridge, MA, USA) at 2 × 10 5 /ml LTBMC medium.
Culture conditions Contact culture:
Irradiated stromal cells were plated as a confluent layer in a 24-well plate (Costar). CD34-positive cells were cultured on the irradiated stromal layers in X-vivo or Iscove modified Dulbecco medium (IMDM), supplemented with 1% deionized BSA (Cohn fraction V), iron saturated human transferrin (300 g/ml), insulin (100 ng/ml), a mixture of sonicated lipids (20 l/ml, see for preparation under CFUMk). All products were obtained from Sigma (St Louis, MO, USA). When human bone marrow stroma was used as stromal feeder layer, cells were cultured in LTBMC medium. Stem cell factor (10 ng/ml) and/or MGDF (50 ng/ml), both kindly provided by Amgen (Thousand Oaks, CA, USA) were added as indicated in the text.
Non-contact culture:
A transwell insert with a 0.4 m microporous membrane (Costar) was placed above the irradiated stromal layer. CD34-positive cells were cultured in the upper well. The same supplemented medium was used as in the stroma-contact cultures. When human bone marrow stroma was used as stromal feeder layer, cells were cultured in LTBMC-medium.
Stroma plus HPC/non-contact culture:
This system was identical to the non-contact culture, however, CD34-positive cells were cultured both in the upper well and directly on the irradiated stromal layer as well.
In all experiments cells were harvested after 5 or 6 days of culturing. Cells from contact cultures were harvested by vigorous pipeting up and down. The cells were analyzed with immunophenotyping and clonogenic capacity was determined in CFU assays.
Immunophenotyping by flow cytometry
All samples were fixed with 1% paraformaldehyde for 4 min and stored at 4°C in PBS with 0.1% BSA. The samples were assayed within 5 days. The expression of several antigens was measured by direct immunofluorescence with flow cytometry (FacsCalibur; Becton Dickinson). Non-specific binding was blocked with human immunoglobulins. Each sample was incubated at room temperature with mouse mAbs (1:50) for 15 min and assayed after three wash steps with PBS and 0.1% BSA. Appropriate mouse immunoglobulin isotype controls were used.
Megakaryocytes were quantified by mAb against GPIIb/IIIa (phycoerythrin (PE)-conjugated anti-CD41, 5B12, Dako, Glostrup, Denmark) and to GPIIIa (fluorescein(FITC)-conjugated anti-CD61, CLB-thromb/1.c17; CLB, Amsterdam, The Netherlands). After culturing, two populations of cells expressing CD41 or CD61 were obtained. Only cells with high expression of CD41 and/or CD61 were defined as megakary-937 ocytes. Analyses were performed by using these high expression levels. Difference in maturation of megakaryocytes was detected by using FITC-conjugated anti-CD42b mAb (M1638, CLB). FITC-conjugated anti-CD15 mAb (Mma, Becton Dickinson) was used for the detection of early and late myeloid progenitors, and anti-glycophorin A for the detection of erythroid precursors (PE-conjugated JC159, Dako).
Progenitor assays CFU-GM and BFU-E:
Freshly isolated CD34-positive cells or cells harvested after 5 or 6 days of culturing were plated in methylcellulose medium with recombinant cytokines at 500 or 1000 cells per ml. The medium contained rhSCF (50 ng/ml), rhGM-CSF (10 ng/ml) and rhIL-3 (10 ng/ml) (Methocult GF, Stemcell Technologies, Vancouver, BC, Canada). Cultures were incubated at 37°C in 5% CO 2 . Colonies (Ͼ40 cells) and cluster (8-40 cells) were counted at day 14. To assess BFU-E, erythropoietin (3 ng/ml) was added (Methocult GF) and colonies were counted at day 14.
CFU-Mk:
Freshly isolated CD34-positive cells or cells harvested after 5 or 6 days of culturing were plated in a serumfree fibrin clot culture system at 5000 cells per ml. 25 Cells were cultured in 35-mm petri dishes at 37°C in 5% CO 2 and studied after 12 days (freshly isolated CD34-positive cells) or after 7 days (cells harvsted after 5 or 6 days of culturing). Culture medium was composed of IMDM containing 1% deionized BSA (Cohn fraction V), iron saturated human transferrin (300 g/ml), calcium chloride (37 g/ml), insulin (100 ng/ml), a mixture of sonicated lipids (20 l/ml), l-asparagine (20 g/ml), ⑀-amino-caproic-acid (1.4 mg/ml), bovine plasma fibrinogen (1 mg/ml), all obtained from Sigma, horse thrombin (0.06 U/ml; Stago, Asnières, France), stem cell factor (50 ng/ml, Amgen). The lipid mixture was produced by sonicating 7.8 mg cholesterol, 6.2 mg oleid acid and 7.4 mg dipalmitoyl lecithin (all obtained from Sigma) in 10 ml of IMDM (without sodium bicarbonate) containing 1% deionized BSA. Aliquots (20 g/ml) of this mixture were added to the cultures. Colonies were quantified by an indirect immunophosphatase-alkaline labelling (APAAP) technique using the anti-GPIIb/IIIa mAb (anti-CD41, 5B12, Dako) ( Figure 1 ).
Statistical analysis
Results are expressed as the mean ± standard deviation (s.d.). Statistical significance of differences was determined using the Wilcoxon matched-pair signed-rank test. A P value Ͻ0.05 was considered to indicate a statistically significant difference.
Results
Effect of cell concentration on proliferation and differentiation of HPC, cultured on a stromal celline in the presence of MGDF
We assessed the effect of direct contact with stroma on the megakaryocytic development of HPC, by comparing the growth of HPC on stroma in the lower chamber (contact culture) to the growth in the upper chamber of a transwell system (non-contact culture). Since in non-contact cultures the surface is six-fold smaller (upper chamber), as compared to contact cultures (lower chamber), we first determined the optimal cell concentration with respect to proliferation and differentiation. Figure 2 shows an example of three performed experiments, in which was shown that, in non-contact cultures, the increase in absolute cell number was less pronounced with higher cell concentration. Only at an initial cell concentration of 0.5 × 10 5 cells/ml no difference in proliferation between non-contact compared to contact cultures was observed. No significant difference in the percentages of CD41-positive cells (Figure 2a ) and CD34-positive cells (Figure 2b ) at different cell concentrations was observed. Thus, a higher number of cells per unit area, as present in non-contact cultures, inhibited cell proliferation, but did not influence cell differentiation. Therefore, in proliferation assays, a plating concentration of 0.5 × 10 5 cells/ml was used. However, when large numbers of cells were necessary, as for flow cytometric immunophenotyping, a plating concentration of 3.0 × 10 5 cells/ml was used.
Effect of the addition of SCF on differentiation of HPC cultured on a stromal cell line
As SCF has a marked synergistic effect with other cytokines on megakaryocytic development of HPC we first estimated whether in our model addition of SCF modified megakaryocytic development. It appeared that addition of SCF in the presence of MGDF had no additive effect on the megakaryocytic development (Table 1) . However when cells were grown without MGDF, addition of SCF resulted in a significant increase in megakaryocytic development (Table 1) . Therefore, the results of cultures with and without SCF could only be combined when MGDF was present in the cultures (Tables 3  and 4 ). When comparisons were made between culture conditions with and without MGDF, SCF was added in all culture conditions (Tables 2 and 5 ). The presence of either SCF or MGDF or both resulted in significantly less megakaryocytic development in contact cultures, as compared to non-contact cultures (Table 1) . However, without the addition of MGDF and/or SCF no difference in megakaryocytic development was observed between contact compared to non-contact cultures.
Phenotype of proliferating hematopoietic cells cultured on a stromal cell line
HPC grown in the absence of MGDF expanded about 10-fold and about 15-fold in the presence of MGDF, irrespective of whether contact or non-contact cultures were used ( Table 2 ), indicating that addition of MGDF resulted in a higher proliferation rate.
The percentage of cells that expressed the CD34 antigen after 5-6 days of culturing decreased with about 50% in both culture situations (Table 3 ). In contrast, the absolute CD34-positive cell number increased four-to nine-fold ( Table 2 ). The number of CD34-positive cells obtained from cultures where MGDF was added, was significantly higher compared to the cultures where MGDF was absent. Between contact and non-contact cultures no significant difference in CD34 expression was observed. Thus, the highest proliferation of CD34-positive cells occurred in the presence of MGDF.
A significantly higher percentage of CD41-and CD61-positive cells were found in non-contact cultures as compared to Numbers indicating the percentages of the total amount of cells which express CD41, given as mean ± standard deviation (n = 6: −MGDF and n = 10: +MGDF). a Significantly higher than values −SCF (P Ͻ 0.05). b Significantly higher than values in contact cultures (P Ͻ 0.01).
contact cultures (Table 3: 24.2% vs 12.9%, respectively, for CD41 expression and 21.1% vs 12.3%, respectively, for CD61 expression). This was also true when the absolute number of CD41-positive and CD61-positive cells was studied (Table 2) . Thus, direct contact with stroma resulted in a lower percentage and a lower absolute number of CD41-and CD61-positive cells. When CD41-positive cells were analyzed with respect to the co-expression of the CD34 surface antigen, it appeared that in non-contact cultures both the percentage of CD41-positive cells with and without expression of CD34 surface antigen was significantly higher compared to contact cultures (Table 3) . In contact cultures, 37.5% of the CD41-positive cells did not express CD34, whereas in non-contact cultures this percentage was higher (48.2%), indicating an increase in megakaryocyte maturation in non-contact cultures (Table 3) . This was also supported by the expression of CD42b, which was higher in non-contact cultures as compared to contact cultures (Table 3: 5.4% vs 2.8%).
The presence of MGDF resulted in a lower frequency of granulocytic cells as shown after CD15 labelling (plus or CD34-positive cells were cultured under four different culture conditions. Immunophenotyping was performed by flow cytometry after 5-6 days of culturing. Numbers, indicating the percentages of the total number of cells which express the indicated antigen, are given as mean ± standard deviation (n = 14). a Significantly higher than values in contact cultures (P Ͻ 0.01). b Significantly higher than values in non-contact cultures (P Ͻ 0.05). c n = 2.
Table 4
The numbers of granulocytic (G), monocytic (M) and erythroid (E) colonies obtained from cells grown in the presence of MGDF in stroma non-contact and contact cultures Non-contact Contact G-colonies 10.8 ± 3.5 11.3 ± 3.7 G-clusters 5.0 ± 2.9 5.8 ± 2.9 M-colonies 1.4 ± 1.0 1.3 ± 1.5 M-clusters 1.3 ± 1.0 0.9 ± 0.6 E-colonies 29.1 ± 11.4 38.1 ± 15.3
The numbers, reflecting the total number of CFU-GM and BFU-E recovered from 500 cells/ml per culture treatment, are given as mean ± standard deviation (n = 9). No significant differences between various culture conditions are present.
minus MGDF, respectively: 12.9 and 16.3 in contact cultures and 12.4 and 18.2 in non-contact cultures, P Ͻ 0.01, data not shown). There was a trend towards a lower absolute number of CD15-positive cells in non-contact cultures (P = 0.05). However, this difference was not significant (Table 2) . No staining was detected with the anti-glycophorin A mAb (data not shown). Thus, in non-contact cultures with either MGDF or SCF, a selective advantage of megakaryocytic development was observed, whereas a lower percentage of granulocytes developed.
Hematopoietic colony forming potential of HPC cultured on a stromal cell line
The clonogenic capacity of cultured cells were investigated by performing CFU-GM, BFU-E (Table 4) and CFU-Mk (Table  5) . No significant differences were observed in clonogenic capacity between cells harvested from non-contact cultures compared to contact cultures. Although there was no significant difference in megakaryocytic clonogenic capacity, there was a trend towards larger megakaryocyte colonies (Ͼ10 cells), without a decline in small colonies, when cells had been cultured in the presence of MGDF, as compared to cells cultured without MGDF.
Stroma plus HPC/non-contact stromal cell line cultures
Stroma plus HPC/non-contact cultures were performed to address the question whether direct contact between HPC and stroma below the transwell induces the production of an inhibitory diffusible cytokine. HPC were cultured not only in the upper well, but simultaneously directly on the stromal layer as well. The percentage of megakaryocytes in the upper well was the same, whether HPC were cultured simultaneously below the transwell or not (Table 6 : CD41-expression; 20.9% vs 22.8% respectively, CD61-expression; 21.4% vs 24.3%, respectively), indicating that no inhibitory diffusible cytokine was induced, which did affect megakaryocytic development of HPC in the upper well. Like the experiments described before (Table 3 ) a higher percentage of megakaryocytes was obtained out of non-contact cultures 940 The numbers, reflecting the total number of CFU-Mk, recovered from 5000 cells/ml per culture treatment, are given as mean ± standard deviation (n = 7 in case of +MGDF, n = 2 in case of −MGDF). No significant differences are present between the different culture conditions, however, a trend toward larger colonies in the presence of MGDF is present. 12.4 ± 7.8
Numbers reflect the percentages of the total number of harvested cells which express CD41 after 5-6 days culturing under various culture conditions. BM, bone marrow; LF, leukapheresis material. Non-contact and contact cultures were initiated as described (Table 2 ). In the stroma + HPC/non-contact cultures (last two columns), HPC were cultured both in the transwell and directly on stroma below the transwell. Cells in stroma + HPC/non-contact cultures were harvested from both the transwell (column 5) as well as from stroma below the transwell (column 6). compared to contact cultures (Table 6 ; 22.8% vs 15.2%, respectively). The results were similar, irrespective of the source of HPC.
Phenotype of proliferating hematopoietic cells cultured on primary human bone marrow stroma
To investigate whether the observed differences in megakaryocytic development of HPC between contact and non-contact cultures are physiologically relevant, some experiments were performed on human bone marrow stroma instead of on the rh-IL3 transfected murine stromal cell line. Similar to the results using the stromal cell line (Table 3 ) from non-contact cultures, in six of seven independent experiments, a higher percentage of CD41-positive cells was harvested as compared to contact cultures (38.4 ± 18.7% vs 28.8 ± 11.2%, respectively, n = 7, P = 0.06). Equal to the findings on the stromal celline (Table 3) , in non-contact cultures the percentage of CD41-positive cells without expression of CD34 surface antigen was significantly higher compared to in contact cultures (55.8 ± 14.6% vs 40.8 ± 18.0%, n = 7, P Ͻ 0.05), indicating a larger increase in megakaryocyte maturation in non-contact cultures.
Discussion
Megakaryocytopoiesis is regulated by cytokines on the one hand and cell-adhesive interactions on the other hand. The effects of various combinations of cytokines on different aspects of megakaryocytopoiesis has been extensively studied for the last few years. 12, [26] [27] [28] [29] [30] [31] Progress was made especially when the recently defined Mpl-ligand was characterized and found to be the principal regulator of megakaryocytopoiesis. [4] [5] [6] [7] [8] However, the influence of cell-adhesive interactions in this process has been less clarified. The interaction between HPC and stroma is thought to modulate the regulation of hematopoiesis. Evidence that stem cells bind to stroma came mostly from experiments using long-term bone marrow cultures (LTBMC). More mature precursors and terminally differentiated cells were found as non-adherent cells in suspension, while stem cells and immature precursors were tightly adhered to the stroma. [32] [33] [34] This raises the possibility that a major role of stroma lays in protecting stem cells from differentiation and proliferation by providing tight adhesion, whereas upon detachment progenitors become susceptible to stromal cytokines inducing differentiation, thereby controlling growth and development of HPC. However, the exact role of these processes on megakaryocytopoiesis remains to be elucidated.
In the present paper we have shown that megakaryocytic development out of HPC and maturation of megakaryocytes, induced by MGDF, is negatively influenced by direct contact with stroma. The possibility that direct contact between HPC and stroma, inducing the production of soluble inhibitory cytokines, for example TGF-beta, would be responsible for this, was excluded by transwell experiments in which HPC were cultured in direct contact with stroma and in a transwell simultaneously. From that, we conclude that the reduction in megakaryocytic differentiation and proliferation of HPC in contact cultures, compared to non-contact cultures, is likely due to either direct adhesive interactions between HPC and stroma or to the presence of cytokines bound to the membrane of stromal cells.
This reduction may be accounted for by modulation of differentiative capacity of megakaryocytic precursors through cell-adhesive interactions with stromal cells. 14, 15, 35 In this regard, it is of interest to note that adhesion of megakaryocytes to stroma leads to suppression of proplatelet formation, the final stage of megakaryocytic differentiation. 36 It may thus be hypothesized that in our model, the interaction between stroma and HPC delays megakaryocytic differentiation of HPC, which is supported by the fact that the co-expression of CD34 antigen on CD41-and CD61-positive cells is lower in the non-contact cultures as compared to contact cultures. In concordance with that, the expression of CD42b is higher in non-contact cultures, pointing towards an increase in maturation in non-contact cultures.
Furthermore, differential proliferative behavior of HPC in contact and non-contact cultures might be underlying the observed differences in megakaryocytopoiesis. Verfaillie showed that conservation of HPC and the generation of granulocytic and monocytic progenitors in LTBMC occurred to a greater extent when HPC were grown separated from a human bone marrow stromal layer instead of in direct contact with stroma. 37 It was shown that not only growth inhibitory soluble cytokines may play a role in the behavior of HPC, but in addition growth inhibitory signals that result from direct adhesive interactions. [37] [38] [39] This may also affect megakaryocytic development, however the development of megakaryocytic progenitors was not investigated in these studies. Although in the study of Verfaillie human bone marrow stroma was used instead of the rh-IL3 engineered M2-10B4 used in our experiments, this is of no great importance, since with respect to supporting in vitro hematopoiesis both stromal sources were found to be similar. 24, 33 Furthermore, in our experiments, the selective advantage for megakaryocytic development of HPC and the increase in maturation status in non-contact cultures, were observed irrespective of the source of the stromal layer.
In the present study we investigated whether megakaryocytic clonogenic capacity was affected by adhesive interactions between HPC and stroma, by plating cells recovered from contact and non-contact cultures in clonogenic assays. No differences in colony-forming capacity (CFU-Mk) were observed. However, such results are not completely conclusive, since adhesion to stroma may result in growth inhibitory signals specific for megakaryocytic precursors, which are absent when these cells are harvested as single cells and put in the clonogenic plasma clot assay, where stroma is absent. Support for this hypothesis comes from studies showing that BFU-Mk, which maintained adhered to isolated ECM proteins and localized hematopoietic growth factors, indeed did not form colonies. 17 However, we were unable to unravel this any further in our system, as the output of clonogenic CFU-Mk assays with cells harvested from non-contact cultures, using CFU-medium only, can not be compared properly with CFUMk systems performed directly on stroma, in which, apart from the CFU-Mk medium, cytokines produced by stroma are present.
Recently, it has been reported that megakaryocytic clonogenic progenitors adhere better to the ECM-component fibronectin than myeloid clonogenic progenitors. 17, 40 Such adherence may produce growth inhibitory signals as is suggested by our finding that less megakaryocytes develop in contact cultures. Cytokines probably modulate these adhesive interactions as MGDF or SCF were absolutely required in our experiments to observe this inhibitory effect. These cytokines might act by enhancing adhesion of HPC to stroma, thereby negatively influencing the megakaryocytic development of HPC. Such adhesive interactions have been shown previously, eg SCF has been reported to enhance the CD44-mediated adhesion of HPC to hyaluronan 41 and TPO was shown to increase the GPIIb/IIIa function, resulting in the promotion of megakaryocyte adhesion to fibronectin. 42 It may be argued that HPC used in our experiments are not normal, as they are obtained from patients with hematological malignancies and solid tumors. However, HPC from patients with acute myeloid leukemia were harvested after complete remission was reached and the patients with non-Hodgkin lymphoma were found not to exhibit marrow involvement (microscopic examination of bone marrow biopsies was performed). Although it is known that with sensitive techniques malignant cells still might be detected, their effect on megakaryocytic development of HPC is questionable, because of their relatively low incidence. This idea is further strengthened by the fact that no significant differences were found in the number of megakaryocytes obtained from the various sources of HPC.
In conclusion, MGDF induces enrichment of peripheral HPC with megakaryocytes, as well as an increase in CD34-positive cells. Furthermore, a selective advantage for megakaryocytic development occurs in the absence of direct contact with stroma. The underlying mechanism has not completely been elucidated, but it appeared highly likely that not the production of a diffusible cytokine, but modulation of megakaryocytic differentiation of HPC by adhesive interactions with stroma or stroma-derived ECM is responsible. We are currently further exploring these questions. Our findings may have important clinical implications for in vitro stem cell expansion, since stem cell enrichment with megakaryocytic precursors is considered to be an approach for improvement in recovery of platelets after myeloablative therapy. 43, 44 It might be that early megakaryocytic progenitors are better preserved in contact cultures, whereas for obtaining more mature megakaryocytes non-contact cultures are preferred.
